2017 Democratic Republic of the Congo Ebola outbreak
2017 Ebola outbreak in the Democratic Republic of the Congo
2017 Democratic Republic of the Congo Ebola Outbreak[edit]
The 2017 Democratic Republic of the Congo Ebola outbreak was a significant event in the ongoing battle against the Ebola virus disease (EVD). This outbreak occurred in the Bas-Uele province of the Democratic Republic of the Congo (DRC) and was officially declared by the World Health Organization (WHO) on May 12, 2017.

Background[edit]
The Ebola virus is a severe, often fatal illness in humans, with a case fatality rate that can reach up to 90%. The virus is transmitted to people from wild animals and spreads in the human population through human-to-human transmission. The DRC has experienced multiple Ebola outbreaks since the virus was first identified in 1976 near the Ebola River, from which the disease takes its name.
Outbreak Details[edit]
The 2017 outbreak was the eighth recorded in the DRC. It began in a remote area of the Bas-Uele province, which is located in the northern part of the country, bordering the Central African Republic. The index case was identified as a 39-year-old male who presented with symptoms consistent with Ebola, including fever, vomiting, and diarrhea. He died on April 22, 2017.
Subsequent cases were identified among individuals who had contact with the index case, including family members and healthcare workers. The outbreak was contained relatively quickly due to the rapid response by the DRC's Ministry of Health and international partners, including the WHO and Médecins Sans Frontières.
Response and Containment[edit]
The response to the outbreak involved several key strategies:
- **Surveillance and Contact Tracing**: Health officials conducted extensive contact tracing to identify and monitor individuals who had been in contact with confirmed cases.
- **Isolation and Treatment**: Suspected and confirmed cases were isolated to prevent further transmission. Treatment centers were established to provide supportive care to patients.
- **Community Engagement**: Efforts were made to educate the local population about the disease and the importance of reporting symptoms and avoiding contact with infected individuals.
- **Vaccination**: Although the rVSV-ZEBOV vaccine was not used during this outbreak, it was later deployed in subsequent outbreaks in the DRC.

Outcome[edit]
The outbreak was officially declared over on July 2, 2017, after 42 days had passed since the last confirmed case tested negative for the virus. In total, there were 8 confirmed cases and 4 deaths, resulting in a case fatality rate of 50%.
Significance[edit]
The 2017 outbreak highlighted the importance of rapid response and international collaboration in controlling Ebola outbreaks. It also underscored the need for continued vigilance and preparedness in regions at risk for Ebola and other zoonotic diseases.
Related Pages[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian